T2 Biosystems Inc logo

T2 Biosystems Inc

LTS:0A57 (USA)  
$ 0.34 (+1.37%) Dec 24
At Loss
Enterprise V:
$ 24.12M
Volume:
15.69K
Avg Vol (2M):
61.89K
Trade In:
Volume:
15.69K
At Loss
Avg Vol (2M):
61.89K

Business Description

T2 Biosystems Inc logo
T2 Biosystems Inc
NAICS : 325413 SIC : 2835
ISIN : US89853L3024
Description
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.11
Equity-to-Asset -0.65
Debt-to-Equity -1.62
Debt-to-EBITDA -0.48
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -55.42
Distress
Grey
Safe
Beneish M-Score -3.04
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 30.49
9-Day RSI 28.09
14-Day RSI 26.58
6-1 Month Momentum % -91.38
12-1 Month Momentum % -98.32

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.4
Quick Ratio 0.24
Cash Ratio 0.09
Days Inventory 122.46
Days Sales Outstanding 71.1
Days Payable 55.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -39.9
Shareholder Yield % 113.51

Financials (Next Earnings Date:2025-02-14 Est.)

LTS:0A57's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

T2 Biosystems Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 7.677
EPS (TTM) ($) -6.418
Beta 33.8
Volatility % 143.77
14-Day RSI 26.58
14-Day ATR ($) 0.051005
20-Day SMA ($) 0.46362
12-1 Month Momentum % -98.32
52-Week Range ($) 0.325 - 28.6
Shares Outstanding (Mil) 21.04

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

T2 Biosystems Inc Filings

Filing Date Document Date Form
No Filing Data

T2 Biosystems Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

T2 Biosystems Inc Frequently Asked Questions

What is T2 Biosystems Inc(LTS:0A57)'s stock price today?
The current price of LTS:0A57 is $0.34. The 52 week high of LTS:0A57 is $28.60 and 52 week low is $0.33.
When is next earnings date of T2 Biosystems Inc(LTS:0A57)?
The next earnings date of T2 Biosystems Inc(LTS:0A57) is 2025-02-14 Est..
Does T2 Biosystems Inc(LTS:0A57) pay dividends? If so, how much?
T2 Biosystems Inc(LTS:0A57) does not pay dividend.

Press Release

Subject Date
No Press Release